You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 143 No. 7, July 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Urine Drug Screening in Mothers and Newborns

John D. Osterloh, MD, MS; Belle L. Lee, PharmD

Am J Dis Child. 1989;143(7):791-793.


Abstract

• A retrospective analysis of comprehensive urine drug screening was performed during a 13-month period on specimens submitted from the Neonatal Nursery and Obstetrics/Gynecology wards at San Francisco (Calif) General Hospital (mothers, N = 601; newborns, N =339). Of mothers and newborns, respectively, 19.2% and 15.3% of all admissions during this period were screened; 68.2% and 63.1% of urine samples submitted were positive for any drug; 38.8% and 21.1% of screens were positive for more than one drug; and 45.8% and 41.6% were positive for cocaine. In mother-newborn pairs (N = 191) where urine samples were submitted within 4 days of each other, an 84% concordance was shown for cocaine and 67% for methadone, but concordance was much less for other drugs (<21%). These results indicate that cocaine was the most common drug detectable in the peripartum period and that both mothers and newborns should be tested to confirm the suspicion of drug effect or withdrawal in the newborn.

(AJDC. 1989;143:791-793)



Author Affiliations

From the Departments of Laboratory Medicine (Dr Osterloh) and Medicine (Drs Osterloh and Lee), University of California, San Francisco, and San Francisco Public Health Toxicology Laboratory (Dr Osterloh).


Footnotes

Accepted for publication March 6, 1989.

Reprint requests to San Francisco General Hospital, Bldg 30, Fifth Floor, 1001 Potrero Ave, San Francisco, CA 94110 (Dr Osterloh).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.